W.R. Berkley Corp’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

W.R. Berkley Corp’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-207,712	Closed	-$2.17M	–	273
2023 Q1	$2.17M	Hold	207,712	–	–	0.14%	97
2022 Q4	$2.12M	Hold	207,712	–	–	0.11%	141
2022 Q3	$2.08M	Hold	207,712	–	–	0.1%	209
2022 Q2	$2.07M	Hold	207,712	–	–	0.1%	189
2022 Q1	$2.07M	Hold	207,712	–	–	0.11%	195
2021 Q4	$2.05M	Buy	+207,712	New	+$2.06M	0.11%	199

W.R. Berkley Corp's LVAC Position: Q2 2023 in Review

W.R. Berkley Corp sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 207,712 shares — an estimated $2.17M sold.

W.R. Berkley Corp first reported a position in LVAC in Q4 2021 and held it in 6 quarters. The position peaked at $2.17M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

W.R. Berkley Corp reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
W.R. Berkley Corp sold 207,712 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2.17M.
W.R. Berkley Corp first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 6 quarters.
W.R. Berkley Corp's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $2.17M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on W.R. Berkley Corp's 13F filing for Q2 2023, filed 14 Aug 2023.